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Abstract 
Since 1992, Denmark has documented the largest outbreak of tuberculosis in 
Scandinavia ascribed to a single genotype, termed ‘C2/1112-15’. As of spring 2017, the 
International Reference Laboratory of Mycobacteriology in Copenhagen has collected 
and identified isolates from more than a thousand cases belonging to this outbreak via 
routine MIRU-VNTR typing. Here, we present a retrospective analysis of the C2/1112-15 
dataset, based on whole-genome data from a sparse time-series consisting of five 
randomly selected isolates from each of the 23 years. Even if these data are derived from 
only 12% of the collected isolates, we have been able to extract important key 
information, such as mutation rate, conserved single-nucleotide polymorphisms to 
identify discrete transmission chains, as well as the possible historical origins of the 
outbreak.   
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Introduction 
Over the last two and a half decades, Denmark has experienced the largest sustained 
outbreak of tuberculosis (TB) in Scandinavia ascribed to a single genotype. Based on 
nationwide strain-typing of every Mycobacterium tuberculosis (Mtb) culture-positive 
case since 1992, it has been documented to progress at a surprisingly high rate 1–3. 
Initially, the outbreak was identified by IS6110 Restriction Fragment Length 
Polymorphism (IS6110-RFLP) genotyping and termed “Cluster 2” based on it being the 
second largest Danish epidemic cluster at the time1. Since, it has been identified through 
the now widely used 24 locus Mycobacterial Interspersed Repetitive Units – Variable 
Number of Tandem Repeats (MIRU-VNTR) typing method as the genotype 1112-154. 
From 1992 through 2014, a total of 989 isolates belonging to C2/1112-15 (hereafter, 
just C2) were registered. Over the same period, the proportion of C2 increased from two 
(8/375) to fifteen percent of annually typed cases (56/365; own data). The majority of 
cases have been reported among Danish-born (DB) and Greenlandic-born (GB) males, 
especially within socially marginalized groups. Until recently, the outbreak was 
considered an isolated Danish problem, but transmission of the C2 genotype to 
Greenland4 as well as neighboring countries (as of yet unpublished data) has since been 
observed. 
A significant limitation with conventional strain genotyping is the lack of resolution to 
establish an exact chronology of transmission events. With the advent of whole-genome 
sequencing (WGS) and the increased availability of low-cost high-throughput 
sequencing platforms, the capacity to elucidate mutational landscapes and transmission 
has greatly enhanced the field of genomic epidemiology5. Although recent studies have 
used WGS to study the changes of Mtb during outbreaks5–7, some even long-term 
continuous transmission8, our knowledge about transmission and evolutionary 
dynamics of outbreaks over decades remain relatively limited. Here we report 
molecular characterization of the Danish C2 outbreak based on a representative time-
series spanning the period 1992-2014. 
Materials and Methods 
Study population 
The TB-incidence in Denmark pr. 100,000 over the selected period (1992-2014) ranged 
from 6-10 and was 7.1 by the end of 20149–11. During the same period, a total of 9,501 
Danish TB cases were culture-positive, from which 94% had at least one Mtb isolate 
successfully genotyped. Out of all typed isolates, 61% clustered with other cases [2,415 
DB; 396 GB; 2,653 foreign-born (FB)], and 39% remained un-clustered [972 DB; 41 GB; 
2481 FB]. Isolates from 989 cases [694 DB; 240 GB; 55 FB] were assigned to the C2 
outbreak with either IS6110-RFLP or MIRU-VNTR typing, comprising 18% of all 
clustered Danish cases over the 23-year sampling period. The C2 cases were 
predominantly male (735/989) and from pulmonary TB (950/989). 
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Study design 
In order to limit the number of isolates to be sequenced, we designed a sparse 
retrospective time-series, in which five isolates were picked from each year over the, 
which comprises 12% (115/989) of C2-typed isolates. Other than cases ideally being DB 
and from the Greater Copenhagen area, where C2 was first reported1, isolates were 
picked at random.  
Whole-genome sequencing and variant calling 
DNA isolation and library preparation of Mtb isolates was performed as previously 
described12. Sequencing was conducted on Illumina MiSeq and NextSeq 500 platforms, 
using 2 × 150 bp paired-end chemistry. Libraries were diluted an extra four-fold when 
run on the Illumina NextSeq 500 sequencing platform. Paired-end reads were trimmed 
and quality filtered prior to variant calling as previously described13. Briefly, adapter 
fragments and low-quality reads were first removed with Trimmomatic14. Reads were 
then mapped to the Mtb H37Rv reference genome using BWA (http://bio-
bwa.sourceforge.net/) and raw variants were called with samtools and bcftools 
(http://www.htslib.org/) using multi-sample pileups. Filtering criteria for VCF-
formatted variants included a minimum read depth of 10 and a minimum variant 
coverage of at least 5 reads in at least one sample. Furthermore, variants were only 
considered at positions where the highest SNP-frequency exceeded 85%. Finally, all 
variants located in repetitive regions, such as pe-, ppe-, pe_pgrs-genes and transposons 
were removed. Sequences have been deposited in the European Nucleotide Archive 
under project accession number PRJEB20214.  
Phylogenetic analysis 
To compare with global Mtb SNPs, sequences from known representatives of Mtb-
lineages 2-5, as well as members of lineage 4.8 were downloaded from the European 
Nucleotide Archive (Table S1) and variants were called in the same manner as 
described above. Multiple sequence alignments consisting of concatenated SNPs were 
generated from filtered vcf-files using an in-house perl script. Variants were assigned as 
missing at a given position if read coverage was less than five reads in that sample, and 
assigned as the reference if the SNP-frequency was below 70%. Positions with more 
than 5% missing bases were removed from the final alignment. Maximum likelihood 
trees were inferred with the program PHYML using the substitution model GTR, which 
consistently scored best with JMODELTEST. 
Bayesian age estimation and phylogeny 
We used BEAST (http://beast.bio.ed.ac.uk/) to infer Bayesian phylogeny and coalescent 
analysis on alignments consisting of concatenated SNPs. Briefly, clock rate and evolution 
model selection was performed as described previously15. The winning model (constant 
molecular clock with exponential population model) was run for 20 million iterations, 
with sampling every 1,000 states. To determine the evolutionary distance between the 
C2 and SAM5 sets (uncorrelated relaxed lognormal molecular clock with Bayesian 
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Skyline evolution model) the analysis ran for 50 million iterations. Monte Carlo Markov 
chain equilibrium and convergence of three independent chains was confirmed using 
TRACER (http://tree.bio.ed.ac.uk/software/tracer/). GENEIOUS 
(http://www.geneious.com/) was used to calculate consensus trees from trees 
generated in the first Markov chain, using a 70% support threshold and a 5% burn-in.   
Results 
MTBC lineage assignment and phylogenetic placement of C2 outbreak 
We used the SNP-based nomenclature proposed by Coll et al16 to assign the subset of C2 
isolates to one of the currently defined MTBC sublineages. In all 115 isolates, we 
detected the GAC/GAT synonymous SNP at codon 51 of the Rv3417c gene, specific to 
MTBC sublineage 4.8 (L4.8), which extends from MTBC lineage 4 (Euro-American). 
 To determine phylogenetic relationships between C2 and related outbreaks in the 
literature, we screened publically available genomes for the L4.8 lineage-specific SNP-
marker and retrieved a total of 254 genomes. Additionally, we retrieved 34 genomes 
from a global set of MTBC lineages 2-5, representing the three “modern” lineages 2-417, 
with a single lineage 5 isolate serving as an outgroup. Three of the included global 
reference isolates (L4_DY8, L4_N0109 and L4_V293AE) also contain the L4.8 marker.  
From the resulting phylogeny, we observed that C2 constitutes a relatively deep-
branching clade within L4.8 and is distinct from other outbreaks currently in the 
literature (Figure 1a). Upon closer inspection (Figure 1b), C2 extends from a diverse 
clade of isolates, all collected from Samara, Russia (2008-2010)18.  
To quantify clonal diversity, we then determined the number of pairwise SNPs between 
C2 and all other L4.8 isolates (Figure 1c). The mean SNP distance from C2 to the rest of 
L4.8 was 293 SNPs, while the mean SNP distance from C2 to the H37Rv reference (L4.9) 
was 345. A small clade consisting of five Samara-isolates (hereafter: SAM5) stood out as 
being more closely related (mean distance: 154 SNPs) to C2 than all other L4.8 isolates. 
We have recently described other isolates collected within the Danish Kingdom, 
including an outbreak in East Greenland (GE) collected 1992 – 2012 and a set of two 
linked Danish cases (Mu) from 1961 and 1994 that also harbor the L4.8 genotype13,19. 
However, neither study included 1112-15 MIRU-type isolates, and we observed quite a 
large distance between C2 and GE- and Mu (mean SNP distance: 313 and 294, 
respectively). Thus, consistent with the underlying genotyping data, we did not find 
genetic evidence linking these three studies. 
C2 displayed a slightly bimodal distribution of pairwise SNP distances (Figure 1d), 
pointing to the presence of distinct clades. Based on the initial phylogenetic analysis, we 
defined the two clades C2-Mj (107 isolates) and C2-Mn (8 isolates). The mean within-
clade minimum pairwise distance of C2-Mj and C2-Mn were 1.9 and 1.5 SNPs, 
respectively, and the between-clade mean pairwise distance was 19 SNPs. 
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Molecular clock analysis and demographic reconstruction 
For a more detailed analysis, and to take advantage of the strict serial sampling strategy, 
we first constructed a maximum parsimony phylogeny from a core set of 237 SNPs, 
specific to C2. We then used TEMPEST to estimate ‘clockiness’ of our data20. Using linear 
regression analysis of tip dates versus root-to-tip distances, we confirmed the presence 
of a strong clock-like signal (P = 5.5 x 10-12) with an average mutation rate of 0.21 per 
genome per year. The resulting time of most recent common ancestor (tMRCA) was 
within the first half of 1960 CE (Figure S1).  
We used BEAST to perform phylogenetic analysis for a more robust estimation of 
mutation- and growth rate of the outbreak. We evaluated nine different Bayes models 
and found a constant molecular clock model within an exponentially growing population 
to be the best fit (Table S2). The constant clock model consistently scored higher than 
relaxed clock models, regardless of the chosen coalescent model. We arrived at a mean 
mutation rate of 0.24 SNPs per genome per year [95% CI: 0.19 – 0.29], with a tMRCA in 
late 1959 CE [95% CI: 1944 – 1973]. Thus, the two approaches of estimating the C2 
mutation rate were consistent. We also ran the same analyses on a subset of the data in 
which we adjusted the sampling proportion to 0.1 each year by removing samples from 
1992-2000. However, this did not change these and subsequently derived results 
significantly.  
We estimated the historical distance between C2 and SAM5, using an uncorrelated 
relaxed clock with an underlying lognormal distribution, combined with a bayesian 
skyline model, similar to Kay et al15. Using this approach on SNPs defined by C2, SAM5 
and H37Rv (Figure S2), we estimated a tMRCA between C2 and the SAM5 set to 1700 
CE [95% CI: 1597 - 1792].  
From the exponential growth model, we derived a mean posterior growth rate of 0.0744 
[95% CI: 0.0398 – 0.111], corresponding to a doubling time of 9.4 years. A non-
parametric Skygrid model21, which ranked second, followed an almost identical 
trajectory from the tMRCA event until 2005, but displayed a slowing of growth followed 
by a slow declining trend (Figure 2a). The Skygrid model also arrived at a slightly 
younger tMRCA (1961) than the exponential growth model.  
Despite the relatively large credibility interval, the posterior mean growth rate is 
consistent with corresponding MIRU typing data, in which Danish 1112-15 typed 
isolates can be fitted to an exponential growth trend at a rate of 0.0706 (R2 = 0.736, P = 
1.6 x 10-7) against an overall slight decline in total TB cases in Denmark (exponential 
growth rate: -0.0148, P = 0.0015) over the same period (Figure 2b).  
Clustering analysis and identification of robust SNP-markers 
From the set of generated BEAST trees, we constructed a timed consensus phylogeny to 
describe the C2 set from a more epidemiological perspective (Figure 3a). This tree was 
found to be overall congruent with the previously constructed maximum parsimony tree 
(Figure S1), apart from branch lengths, where BEAST incorporates tip dates. The C2-Mj 
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and C2-Mn clades had tMRCAs of 1966 CE and 2000 CE, respectively, meaning that the 
former emerged about 34 years before the latter.  
To infer epidemiological links between C2 isolates for which we currently possess whole 
genome data, we derived a clustering threshold of 7 SNPs from the maximum number of 
possible SNPs over the 23-year sampling period, given the upper credibility limit of the 
BEAST-estimated mutation rate. From this analysis, we could then define three major 
epidemic groups of putatively linked isolates, comprising 89% (Group A; 102 cases), 7% 
(Group B; 8 cases) and 2.6 % (Group C; 3 cases) of C2 cases, respectively. Groups A and C 
lie within the C2-Mj clade while group B engulfs the whole C2-Mn clade. The clustering 
was therefore congruent with the underlying phylogeny. Additionally, almost all 
(100/102) Group A-cases contained a single conserved non-synonymous mutation in 
the gene tcrY (Rv3764c). 
From the consensus tree, we were able to distinguish eight smaller strongly supported 
sub-groups (A.1 – A.7 and B.1), each consisting of five or more isolates. Within each of 
these sub-groups, we used the inferred median root node age to estimate the most likely 
year of their emergence.  We found that six out of eight of the smaller epidemic groups 
originated around or after 1992 (Figure 3b). Thus, in all likelihood, the IRLM strain 
collection possess complete transmission chains for these groups, and would benefit 
from deeper sampling to elucidate patient-to-patient transmission. For the benefit of 
future studies of the C2 outbreak, we therefore devised a SNP-barcode, comprising 
fourteen SNP positions from which to classify isolates into each of the currently eight 
defined epidemic groups (Figure 4). Where possible, we selected synonymous variants, 
to minimize the effect of natural selection, like Coll et al.16 
Transmission dynamics before and during sampling period 
We used TRANSPHYLO22,23 to infer transmission dynamics during- and prior to the 
sampling period, based on the maximum clade credibility tree produced by BEAST 
(Figure S3). We used prior distributions for generation- and sampling times (time 
between infection and transmission, and between infection and sampling, respectively) 
from a previously analyzed TB outbreak24 (Figure S4). From the consensus 
transmission tree, we could then derive the likely number of transmission events each 
year, dating back from 2014 (Figure 3c). According to this analysis, the earliest 
transmission event leading to the current C2 outbreak occurred during 1966, in 
accordance with the emergence of the C2-Mj clade. The transmission-frequency declined 
toward the end of the sampling period, consistent with a median lag time between 
transmission and progression to active disease of one to two years. 
The cumulative number of estimated transmission events prior to 1992 was 119, while 
the total number of transmission events (1966-2014), leading to the 115 sampled cases, 
amounted to 498. Thus, according to our transmission analysis, roughly one quarter of 
total C2 transmissions occurred before systematic collection and typing of TB isolates 
began at the SSI, over a period similar in length (26 years) to the sampling period. 
Ac
ce
pte
d M
an
us
cri
pt
 
9 
 
In TRANSPHYLO, we were also able to extract a number of parameters from posterior 
distributions that describe overall characteristics of the C2 outbreak (Figure S5). The 
mean basic reproductive number R0, defined as the expected number of secondary 
diseases per case in a completely susceptible population, was 1.15 [95% CI: 1.08 – 1.23], 
which is consistent with a moderately expanding TB outbreak (R0 > 1) in a low-burden 
setting22. The mean within-host coalescence rate (Neg) was 1.33 [95% CI: 0.53 – 3.46] 
events per year, corresponding to a within-host effective population size of 485 [95% CI: 
193 – 1263]. The mean sampling proportion () was 0.05 [95% CI: 0.04 - 0.07], which 
was somewhat lower than the mean sampling proportion of typed isolates over the 
sampling period (0.116, from 115/989 isolates; see also Figure 2b).   
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Discussion 
To characterize the largest ongoing clonal TB outbreak (C2) in Scandinavia, we 
subjected a representative time-series of 115 Mtb isolates collected 1992-2014, to WGS. 
The restrained sampling strategy reflects the immense size of this cluster, which by now 
has exceeded one thousand cases. 
Our initial observation from phylogenetic analysis is that C2 consists of two discernible 
clades (Figure 3), one major (C2-Mj) and one minor (C2-Mn), where C2-Mj is the older 
and more diverse of the two. Using molecular dating we arrived at 1959 CE [95% CI: 
1944 – 1973] as the year of initial diversification, pointing to introduction of C2 into 
Denmark sometime after the Second World War. Thus, we estimate that emergence, or 
possibly, the re-emergence, of C2 two to five decades prior to the beginning of routine 
collection and genotyping of Danish TB isolates in 1992. 
We calculated an overall mutation rate of 0.24 SNPs [95% CI: 0.19 – 0.29] per genome 
per year for C2, which agrees well with other studies, typically reporting between 0.2 - 
0.5 SNPs per genome per year25–28. 
We defined three distinct epidemic groups (A, B and C) using a clustering threshold of 7 
SNPs, which we derived from the estimated mutation rate over the 23-year sampling 
period. Thus, even if the underlying sample set was initially defined by a single MIRU-
VNTR genotype (1112-15), our WGS analysis reveals several distinct but historically 
linked transmission chains, even without directly inferring patient-to-patient 
transmissions. Incidentally, if the clustering threshold was increased to include the 
initial year of diversification (1959), the resulting threshold, 16 SNPs over 55 years, 
produced a single cluster containing all 115 C2 isolates. 
The largest of the epidemic groups (Group A) contains 89% (102/115) of the sequenced 
isolates with a consensus tMRCA in 1975, which predates routine typing at the IRLM by 
14 years. We therefore further subdivided Group A into groups consisting of five or 
more isolates with strong clade support (A.1 – A.7). Using the same criteria, we could 
also identify a single subgroup (B.1) inside epidemic group B.  
Even though the C2 dataset consists mainly (108/115) of samples collected over the 
entire greater Copenhagen area, we observed that two of the epidemic groups 
(subgroup A.3 and group B) could be specifically linked to discrete geographic areas 
within the capital region. In subgroup A.3, for example, 10 out of 11 strains stemmed 
from the same postal district with a population size of 36.000, while group B contained 
6 out of 8 cases stemming from an area around a shelter/drop-in center in Copenhagen. 
This agrees with previous studies, in which subclades have been linked 
epidemiologically5,8,19, strengthening the utility of WGS-based subtyping for 
transmission tracing, especially in lieu of detailed epidemiological contact data. Each of 
the eight subgroups can be identified through the presence of one or more conserved 
SNPs, from which we have selected a core set of fourteen for future classification of C2 
isolates (See Table 1).  
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Previously it has been shown that different MIRU-types can be linked into contiguous 
transmission chains with WGS19. Consequently, it is likely that more cases could be 
included in the C2 outbreak if related MIRU-VNTR types from the IRLM collection were 
investigated. Our collection currently holds 45 isolates from 19 different genotypes that 
differ from 1112-15 in only one locus. Isolates from three of these genotypes have so far 
been confirmed to extend from the C2 outbreak using the presented core SNP set 
(unpublished). 
The deep branching of the C2-Mn clade (Group B), which we estimated to originate in 
2000, points to a possible case of reactivation following prolonged latency. Despite the 
lack of a clear index case and the relatively sparse sampling of C2, we deem it unlikely 
that deeper or complete sampling would produce numerous intermediates to challenge 
this. Thus, we find it likely that the nine common SNPs observed in this deep branch 
accumulated during latent infection. In light of prior observations, that mutation 
accumulation can occur during prolonged latency at rates comparable to active 
disease13, we underpin that latent cases continually pose a threat to the emergence of 
new transmission chains29.  
Our analysis also established that the C2 outbreak belongs to MTBC sublineage L4.8. 
Recently, a major study of the Euro-American MTBC Lineage 4 described the newly 
defined L4.10/PGG3 sublineage (combining L4.7, L4.8 and L4.9), as a ‘generalist’ with 
widespread global distribution30. Given that C2 is the largest epidemic cluster in 
Scandinavia, it is unsurprising to find it linked to such a ubiquitous sublineage. The most 
closely related isolates specifically originated from Russia, and we estimated that C2 is 
separated from its closest Russian isolate by at least 200 years. This would suggest 
Russia or possibly Eastern Europe as the historical origin of C2. Interestingly, the 
estimated emergence of C2 in Denmark coincides with the influx of approximately 1,000 
Hungarian immigrants in the wake of the Hungarian Revolution of 1956. A recent study 
by Eldholm et al, exemplified the impact of political instability on the spread and 
diversification of TB31. Unfortunately, apart from a minor collection of Mtb strains from 
the 1960s, which was not found to contain the C2-genotype32, the Danish TB collection 
does not hold isolates from before 1992, making it difficult to delve deeper into this 
hypothesis at this point. 
In conclusion, using WGS on only 12% of culture-verified isolates collected over 23 
years, we have derived key information about the largest ongoing TB-outbreak in 
Scandinavia that was previously only identified as a single genotype. It remains unclear 
whether the success of C2 is attributable to a unique virulence profile but we have so far 
not found evidence to suggest this. Moreover, the extent of the C2 outbreak in Denmark 
has previously been linked to delayed diagnosis1,2. Regardless, our present study 
provides a strong case for strengthening TB control in high-risk groups to curtail active 
transmission and monitor re-activation of latent cases. Consequently, we continue to 
stress the need for sustained TB awareness, even in low-incidence settings such as 
Denmark. In Copenhagen, efforts to screen for TB by sputum culture in high-risk groups 
has been ongoing since 201233. Identification is also important for proper control 
actions, and with this study we provide a simple example of using a SNP-typing scheme, 
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derived from WGS analysis of historical isolates, for rapid classification of discrete 
transmission chains in large ongoing outbreaks.  
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Figure Legends 
Figure 1. Phylogenetic placement of the Danish Cluster-2 (C2) M. tuberculosis outbreak 
based on single-nucleotide polymorphisms (SNPs) of 115 representative C2-isolates in 
(a) relation to 33 global MTBC reference strains representing the three “modern” MTBC 
lineages 2-4 (Comas et al. 2013) and (b) in relation to 254 other TB isolates belonging to 
the L4.8 sublineage (indicated as gray in panel a). Large clades where all isolates 
originate from a single country are colored according to the legend (CAN: Canada; DK: 
Danish Kingdom; MLW: Malawi; RUS: Russia; UK: United Kingdom).  The pairwise 
number of SNPs between C2 isolates and the rest of L4.8 (c), and between just the C2 
isolates (d) are shown as histograms. See main text for explanation of the isolate sets GE, 
Mu and SAM5. 
Figure 2. (a) Effective population size of the C2 outbreak over time, including 95% 
confidence intervals, derived from BEAST-analysis based on exponential growth (black 
line) and Bayesian Skygrid (blue lines) coalescent models. Vertical dotted lines on the 
graph represent the estimated time of most recent common ancestor (tMRCA) according 
to the chosen Bayesian model. (b) The log-number of MIRU-typed isolates of either C2 
isolates (red dots) or the total number of isolates from the Danish Kingdom (blue 
circles) fitted to linear regression lines, showing the overall growth trends. The black 
circles indicate the sampling proportion out of total C2 isolates, when picking five 
isolates each year. 
Figure 3. Timed phylogeny based on BEAST consensus tree showing the subdivision of 
C2 into one major (C2-Mj) and one minor (C2-Mn) clade. Highlighted clades A, B and C 
represents clusters of epidemiologically linked isolates, defined by a threshold of  7 
SNPs. All but two isolates in cluster A also harbor a non-synonymous SNP in the H37Rv 
gene tcrY (Rv3674c). Smaller epi-groups A.1-A7 and B.1 are defined by clades of five or 
more isolates with strong clade support (> 70%) on the consensus tree. Horizontal bars 
(b) indicate the timeline of each epidemic group from the estimated time of most recent 
common ancestor (light colored areas) and the period in which representative isolates 
were collected (dark colored areas). The number of transmission events per year, 
inferred from TRANSPHYLO analysis, is shown along the timeline as a histogram (c). The 
vertical black dotted line indicates the year (1992) in which systematic typing of TB 
isolates began at the IRLM. 
Table 1. Overview of core SNPs-set useful for identifying C2 and its major (C2-Mj) and 
minor (C2-Mn) clades, the three epidemic groups A,B & C of epidemiologically linked 
isolates, and eight smaller epidemic groups that are part of the C2 outbreak. 
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1,035,840 C T prrA (Rv0903c) T280C . Two component response transcriptional regulatory protein . . . . T T T T T T T T T .
1,410,569 C G amiB2 (Rv1263) C139G R47G Probable amidase AmiB2 (aminohydrolase) . . . . . . G . . . . . . .
1,467,344 C T atpC (Rv1311) C30T . Probable ATP synthase epsilon chain A 2 . . . . T T T T T T T T T .
1,813,265 C T lgt (Rv1614) C95T T32I Possible prolipoprotein diacylglyceryl transferases . T T . . . . . . . . . . .
1,835,148 C T coaE (Rv1631) C136T . Probable dephospho-CoA kinase C2-Mn/B 9 . T T . . . . . . . . . . .
1,951,980 C T Rv1726 C129T . Probable oxidoreductase . T T . . . . . . . . . . .
2,242,582 G A ctpF (Rv1997) G2424A . Probable metal cation transporter P-type ATPase A A.5 1 . . . . . . . . . . A . . .
2,329,920 G A cobL (Rv2072c) C228T P76L Precorrin-6Y C(5,15)-methyltransferase A.4 1 . . . . . . . . . A . . . .
2,528,014 G A Rv2253 G31A A11T Possible secreted unknown protein . . . . . . . . . . . . . A
2,537,023 A G Rv2264c T1329C V443A Conserved hypothetical proline rich protein . G G . . . . . . . . . . .
2,563,075 G A lppO (Rv2290) G477A M159I Probable conserved lipoprotein . A A . . . . . . . . . . .
2,603,748 G A lppP (Rv2330c) C476T H159Y Probable lipoprotein . A A . . . . . . . . . . .
2,768,599 T C Rv2466c A287G N96D Conserved protein . . . . . . C . . . . . . .
3,290,947 T G lppX (Rv2945c) A380C S127R Probable conserved lipoprotein . . . . . . . . . . . . G .
3,405,449 C T fecB (Rv3044) C314T A105V Probable FEIII-dicitrate-binding periplasmic lipoprotein . . . . . . . . . . . . . T
3,600,762 C T Rv3224A C128T P43L Conserved hypothetical protein . T T . . . . . . . . . . .
3,805,888 G A acrA1 (Rv3391) G268A A90T Possible multi-functional enzyme with acyl-CoA-reductase activity . A A . . . . . . . . . . .
3,904,014 C T cpsA (Rv3484) C937T . Possible conserved protein . T T . . . . . . . . . . .
4,209,859 C A tcrY (Rv3764c) G1152T R384L Possible two component sensor kinase TcrY 1 . . . . . A A A A A A A A .
N
o. conserved
SN
Ps
